These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8628496)

  • 41. Quantitative assessment of neuromuscular deficit in ALS.
    Andres PL; Thibodeau LM; Finison LJ; Munsat TL
    Neurol Clin; 1987 Feb; 5(1):125-41. PubMed ID: 3550414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials.
    Rutkove SB; Zhang H; Schoenfeld DA; Raynor EM; Shefner JM; Cudkowicz ME; Chin AB; Aaron R; Shiffman CA
    Clin Neurophysiol; 2007 Nov; 118(11):2413-8. PubMed ID: 17897874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of physical impairment on emotional well-being in ALS.
    Abdulla S; Vielhaber S; Kollewe K; Machts J; Heinze HJ; Dengler R; Petri S
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):392-7. PubMed ID: 25008979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality of life in ALS is maintained as physical function declines.
    Robbins RA; Simmons Z; Bremer BA; Walsh SM; Fischer S
    Neurology; 2001 Feb; 56(4):442-4. PubMed ID: 11222784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution of quality of life, mental health, and coping strategies in amyotrophic lateral sclerosis: a pilot study.
    Montel S; Albertini L; Desnuelle C; Spitz E
    J Palliat Med; 2012 Nov; 15(11):1181-4. PubMed ID: 23039217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inter-evaluator reliability of the ALS functional rating scale.
    Miano B; Stoddard GJ; Davis S; Bromberg MB
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):235-9. PubMed ID: 15799553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors which predict physical and mental health status in patients with amyotrophic lateral sclerosis over time.
    Norquist JM; Jenkinson C; Fitzpatrick R; Swash M;
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Jun; 4(2):112-7. PubMed ID: 14506943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1a.
    Miller DM; Weinstock-Guttman B; Bourdette D; You X; Foulds P; Rudick RA
    Mult Scler; 2011 Jun; 17(6):734-42. PubMed ID: 21300736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Observational study of patients in Spain with amyotrophic lateral sclerosis: correlations between clinical status, quality of life, and dignity.
    Martínez-Campo Y; Homedes C; Lazaro A; Alarcón R; Campo D; Riera M; Domínguez R; Povedano M; Casasnovas C
    BMC Palliat Care; 2017 Dec; 16(1):75. PubMed ID: 29258495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].
    Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S
    No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patients' self-perceived burden, caregivers' burden and quality of life for amyotrophic lateral sclerosis patients: a cross-sectional study.
    Geng D; Ou R; Miao X; Zhao L; Wei Q; Chen X; Liang Y; Shang H; Yang R
    J Clin Nurs; 2017 Oct; 26(19-20):3188-3199. PubMed ID: 27874996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant growth hormone treatment of amyotrophic lateral sclerosis.
    Smith RA; Melmed S; Sherman B; Frane J; Munsat TL; Festoff BW
    Muscle Nerve; 1993 Jun; 16(6):624-33. PubMed ID: 8502260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rasch measurement in the assessment of amytrophic lateral sclerosis patients.
    Norquist JM; Fitzpatrick R; Jenkinson C
    J Appl Meas; 2003; 4(3):249-57. PubMed ID: 12904675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitating progression in ALS.
    de Carvalho M; Scotto M; Lopes A; Swash M
    Neurology; 2005 May; 64(10):1783-5. PubMed ID: 15911812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis.
    de Carvalho M; Scotto M; Lopes A; Swash M
    Muscle Nerve; 2003 Nov; 28(5):630-3. PubMed ID: 14571468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort.
    Körner S; Kollewe K; Abdulla S; Zapf A; Dengler R; Petri S
    BMC Neurol; 2015 May; 15():84. PubMed ID: 25982050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The SEIQoL-DW for assessing quality of life in ALS: strengths and limitations.
    Felgoise SH; Stewart JL; Bremer BA; Walsh SM; Bromberg MB; Simmons Z
    Amyotroph Lateral Scler; 2009; 10(5-6):456-62. PubMed ID: 19922140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Caregiver burden and patients' perception of being a burden in ALS.
    Chiò A; Gauthier A; Calvo A; Ghiglione P; Mutani R
    Neurology; 2005 May; 64(10):1780-2. PubMed ID: 15911811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
    Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
    Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.